PubMed · 9182048
Setting exposure standards: a decision process.
Abstract
Increased emphasis on routine screening of chemicals for potential neurotoxicity has resulted in the development of testing guidelines and standardized procedures. A multiphased, tiered-testing strategy has been proposed by numerous expert panels to evaluate large numbers of chemicals. In a regulatory context, however, a formal tiered-testing approach is not used, mostly because of the constraints of differing regulatory authorities and the potential cost of such a testing strategy. Instead, current regulatory decision making utilizes all available animal and human data to identify a critical adverse effect which is then used for setting standards. Although the current decision-making process does not use a formal tiered-testing approach, it appears to identify chemicals with neurotoxic effects. An analysis of U.S. Environmental Protection Agency integrated risk information system (IRIS) indicates that about 20% of the chemicals having standards or health advisories are based on neurotoxicity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
H A Tilson, R C MacPhail, K M Crofton. 1996. Setting exposure standards: a decision process.. https://doi.org/10.1289/ehp.96104s2401. https://searchpubmed.org/record/pubmed%3A9182048/setting-exposure-standards-a-decision-process
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.